Literature DB >> 33123991

HGF/c-Met Signalling in the Tumor Microenvironment.

Alberto Zambelli1, Giuseppe Biamonti2, Angela Amato3.   

Abstract

Recently, it has become clearer that tumor plasticity increases the chance that cancer cells could acquire new mechanisms to escape immune surveillance, become resistant to conventional drugs, and spread to distant sites.Effectively, tumor plasticity drives adaptive response of cancer cells to hypoxia and nutrient deprivation leading to stimulation of neoangionesis or tumor escape. Therefore, tumor plasticity is believed to be a great contributor in recurrence and metastatic dissemination of cancer cells. Importantly, it could be an Achilles' heel of cancer if we could identify molecular mechanisms dictating this phenotype.The reactivation of stem-like signalling pathways is considered a great determinant of tumor plasticity; in addition, a key role has been also attributed to tumor microenvironment (TME). Indeed, it has been proved that cancer cells interact with different cells in the surrounding extracellular matrix (ECM). Interestingly, well-established communication represents a potential allied in maintenance of a plastic phenotype in cancer cells supporting tumor growth and spread. An important signalling pathway mediating cancer cell-TME crosstalk is represented by the HGF/c-Met signalling.Here, we review the role of the HGF/c-Met signalling in tumor-stroma crosstalk focusing on novel findings underlying its role in tumor plasticity, immune escape, and development of adaptive mechanisms.

Entities:  

Keywords:  Adipokines; Cancer cell plasticity; Cancer stem cells (CSCs); Cellular crosstalk; Drug resistance; HGF/c-Met signalling; Hepatokines; Immune escape; Inflammation; Mesenchymal stem cells (MSCs); Metabolic stress; Metastasis; Neo-angiogenesis; Tumor heterogeneity; Tumor microenvironment (TME)

Mesh:

Substances:

Year:  2021        PMID: 33123991     DOI: 10.1007/978-3-030-47189-7_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  CircFAM53B promotes the proliferation and metastasis of glioma through activating the c-MET/PI3K/AKT pathway via sponging miR-532-3p.

Authors:  Jiaping Pei; Hui Dou; Xiaozhao Deng
Journal:  Cell Cycle       Date:  2022-01-31       Impact factor: 4.534

Review 2.  Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies.

Authors:  Zhengyang Yang; Wei Deng; Xiao Zhang; Yongbo An; Yishan Liu; Hongwei Yao; Zhongtao Zhang
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

3.  TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma.

Authors:  Xinhua Xiao; Huizhuang Shan; Yangyang Niu; Peihong Wang; Donghe Li; Yuyin Zhang; Jiayi Wang; Yingli Wu; Hua Jiang
Journal:  Front Mol Biosci       Date:  2022-04-26

Review 4.  HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence.

Authors:  Jianjiang Fu; Xiaorui Su; Zhihua Li; Ling Deng; Xiawei Liu; Xuancheng Feng; Juan Peng
Journal:  Oncogene       Date:  2021-06-18       Impact factor: 9.867

5.  Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration.

Authors:  Rupa Guha; Binbin Yue; Jianping Dong; Aditi Banerjee; Ginette Serrero
Journal:  Breast Cancer Res Treat       Date:  2021-02-22       Impact factor: 4.872

Review 6.  Roles for growth factors and mutations in metastatic dissemination.

Authors:  Nishanth Belugali Nataraj; Ilaria Marrocco; Yosef Yarden
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 5.407

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.